Lam Research Cash & Equivalents decreased by 23.1% to $4.77B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.7%, from $5.46B to $4.77B. Over 4 years (FY 2021 to FY 2025), Cash & Equivalents shows an upward trend with a 8.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.67B | $4.29B | $5.34B | $4.45B | $3.77B | $4.51B | $4.74B | $5.56B | $5.59B | $5.13B | $5.63B | $5.67B | $5.85B | $6.07B | $5.68B | $5.46B | $6.41B | $6.71B | $6.20B | $4.77B |
| QoQ Change | — | -8.1% | +24.3% | -16.7% | -15.1% | +19.4% | +5.1% | +17.3% | +0.6% | -8.2% | +9.7% | +0.9% | +3.1% | +3.8% | -6.5% | -3.8% | +17.3% | +4.7% | -7.7% | -23.1% |
| YoY Change | — | — | — | — | -19.2% | +5.0% | -11.3% | +25.0% | +48.1% | +13.7% | +18.8% | +2.1% | +4.7% | +18.4% | +0.9% | -3.7% | +9.5% | +10.5% | +9.1% | -12.7% |